Ocugen Historical Income Statement

OCGN Stock

USD 0.83 0 0.12%

Historical analysis of Ocugen income statement accounts such as Total Revenue of 7.3 M can show how well Ocugen Inc performed in making a profits. Evaluating Ocugen income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Ocugen's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Ocugen Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Ocugen Inc is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

About Ocugen Income Statement Analysis

Ocugen Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Ocugen shareholders. The income statement also shows Ocugen investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Ocugen Income Statement Chart

At this time, Ocugen's Total Other Income Expense Net is very stable compared to the past year. As of the 9th of January 2025, Income Tax Expense is likely to grow to about 506.6 K, while Depreciation And Amortization is likely to drop about 582.4 K.

Selling General Administrative Other Operating Expenses Research Development Ebitda Total Operating Expenses Preferred Stock And Other Adjustments

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Ocugen Inc. It is also known as Ocugen overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most accounts from Ocugen's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Ocugen Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Ocugen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Ocugen income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Interest Income	Net Income From Continuing Ops	Cost Of Revenue	Non Recurring	Non Operating Income Net Other	Net Interest Income	Reconciled Depreciation
Depreciation And Amortization		-0.24	-0.1	-0.09	-0.25	-0.01	0.02	-0.05	0.12	-0.03	-0.01	0.04	0.15	0.04	-0.17	0.05	0.07	0.7	-0.4	0.6	-0.26	0.67
Interest Expense	-0.24		0.9	0.92	0.8	0.85	-0.74	-0.68	0.65	-0.69	0.85	-0.77	-0.01	-0.77	0.14	-0.26	-0.72	-0.42	0.66	-0.15	0.63	-0.54
Selling General Administrative	-0.1	0.9		0.88	0.72	0.98	-0.92	-0.87	0.83	-0.87	0.98	-0.9	0.12	-0.91	0.03	-0.17	-0.84	-0.37	0.69	-0.06	0.75	-0.53
Total Revenue	-0.09	0.92	0.88		0.94	0.85	-0.68	-0.63	0.62	-0.63	0.85	-0.68	0.05	-0.69	0.16	-0.22	-0.67	-0.29	0.55	-0.06	0.56	-0.36
Gross Profit	-0.25	0.8	0.72	0.94		0.65	-0.44	-0.38	0.38	-0.39	0.65	-0.48	-0.06	-0.49	0.28	-0.2	-0.49	-0.38	0.5	-0.16	0.48	-0.38
Other Operating Expenses	-0.01	0.85	0.98	0.85	0.65		-0.95	-0.91	0.89	-0.91	1.0	-0.91	0.17	-0.91	-0.03	-0.17	-0.87	-0.24	0.58	0.01	0.66	-0.43
Operating Income	0.02	-0.74	-0.92	-0.68	-0.44	-0.95		0.96	-0.94	0.96	-0.95	0.94	-0.23	0.94	0.12	0.11	0.87	0.25	-0.57	-0.01	-0.67	0.45
Ebit	-0.05	-0.68	-0.87	-0.63	-0.38	-0.91	0.96		-0.9	1.0	-0.91	0.82	-0.47	0.82	0.38	-0.1	0.73	0.25	-0.53	-0.16	-0.62	0.42
Research Development	0.12	0.65	0.83	0.62	0.38	0.89	-0.94	-0.9		-0.9	0.89	-0.88	0.23	-0.88	-0.14	-0.13	-0.83	-0.07	0.39	0.08	0.51	-0.25
Ebitda	-0.03	-0.69	-0.87	-0.63	-0.39	-0.91	0.96	1.0	-0.9		-0.91	0.82	-0.46	0.82	0.37	-0.1	0.73	0.27	-0.54	-0.15	-0.63	0.44
Total Operating Expenses	-0.01	0.85	0.98	0.85	0.65	1.0	-0.95	-0.91	0.89	-0.91		-0.91	0.17	-0.91	-0.03	-0.17	-0.87	-0.24	0.58	0.01	0.66	-0.43
Income Before Tax	0.04	-0.77	-0.9	-0.68	-0.48	-0.91	0.94	0.82	-0.88	0.82	-0.91		0.11	1.0	-0.2	0.4	0.96	0.2	-0.55	0.08	-0.64	0.44
Total Other Income Expense Net	0.15	-0.01	0.12	0.05	-0.06	0.17	-0.23	-0.47	0.23	-0.46	0.17	0.11		0.12	-0.96	0.81	0.19	-0.08	0.03	0.43	0.07	-0.01
Net Income	0.04	-0.77	-0.91	-0.69	-0.49	-0.91	0.94	0.82	-0.88	0.82	-0.91	1.0	0.12		-0.22	0.41	0.96	0.21	-0.56	0.09	-0.65	0.45
Income Tax Expense	-0.17	0.14	0.03	0.16	0.28	-0.03	0.12	0.38	-0.14	0.37	-0.03	-0.2	-0.96	-0.22		-0.8	-0.31	0.07	0.01	-0.39	0.0	0.01
Interest Income	0.05	-0.26	-0.17	-0.22	-0.2	-0.17	0.11	-0.1	-0.13	-0.1	-0.17	0.4	0.81	0.41	-0.8		0.51	-0.17	0.01	0.31	-0.01	-0.01
Net Income From Continuing Ops	0.07	-0.72	-0.84	-0.67	-0.49	-0.87	0.87	0.73	-0.83	0.73	-0.87	0.96	0.19	0.96	-0.31	0.51		0.05	-0.39	0.1	-0.5	0.3
Cost Of Revenue	0.7	-0.42	-0.37	-0.29	-0.38	-0.24	0.25	0.25	-0.07	0.27	-0.24	0.2	-0.08	0.21	0.07	-0.17	0.05		-0.81	0.43	-0.67	0.95
Non Recurring	-0.4	0.66	0.69	0.55	0.5	0.58	-0.57	-0.53	0.39	-0.54	0.58	-0.55	0.03	-0.56	0.01	0.01	-0.39	-0.81		-0.4	0.96	-0.85
Non Operating Income Net Other	0.6	-0.15	-0.06	-0.06	-0.16	0.01	-0.01	-0.16	0.08	-0.15	0.01	0.08	0.43	0.09	-0.39	0.31	0.1	0.43	-0.4		-0.33	0.37
Net Interest Income	-0.26	0.63	0.75	0.56	0.48	0.66	-0.67	-0.62	0.51	-0.63	0.66	-0.64	0.07	-0.65	0.0	-0.01	-0.5	-0.67	0.96	-0.33		-0.72
Reconciled Depreciation	0.67	-0.54	-0.53	-0.36	-0.38	-0.43	0.45	0.42	-0.25	0.44	-0.43	0.44	-0.01	0.45	0.01	-0.01	0.3	0.95	-0.85	0.37	-0.72

Click cells to compare fundamentals

Ocugen Account Relationship Matchups

Ocugen income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	102.1K	589K	480K	704K	633.6K	582.4K
Interest Expense	1.8M	721.0K	79K	3.5M	4.0M	4.2M
Selling General Administrative	8.0M	22.9M	35.1M	32.0M	36.8M	38.6M
Gross Profit	36.3K	(589K)	(1.1M)	5.3M	6.1M	6.4M
Other Operating Expenses	14.3M	58.0M	84.9M	71.6M	82.3M	86.4M
Operating Income	(21.3M)	(58.0M)	(84.9M)	(65.5M)	(59.0M)	(56.0M)
Ebit	(21.1M)	(58.6M)	(84.9M)	(65.5M)	(59.0M)	(61.9M)
Research Development	6.4M	35.1M	49.8M	39.6M	45.5M	24.3M
Ebitda	(21.0M)	(58.0M)	(84.4M)	(64.8M)	(58.3M)	(61.3M)
Total Operating Expenses	14.3M	58.0M	84.9M	71.6M	82.3M	86.4M
Income Before Tax	(21.8M)	(58.4M)	(81.4M)	(63.1M)	(56.8M)	(53.9M)
Total Other Income Expense Net	(537.0K)	(389K)	3.5M	2.5M	2.8M	2.9M
Net Income	(22.6M)	(58.4M)	(77.8M)	(63.1M)	(56.8M)	(53.9M)
Income Tax Expense	801.5K	(52K)	(4.0M)	536.1K	482.5K	506.6K
Interest Income	20.0M	1.2K	1.1K	16.1K	14.5K	13.7K
Net Income From Continuing Ops	(21.8M)	(58.4M)	(81.4M)	(63.1M)	(56.8M)	(59.6M)
Cost Of Revenue	6.4K	589K	1.1M	704K	633.6K	649.2K
Net Income Applicable To Common Shares	(20.2M)	(34.4M)	(58.4M)	(81.4M)	(73.2M)	(69.6M)
Net Interest Income	(570K)	(1.8M)	(719.9K)	(79K)	(90.9K)	(95.4K)
Reconciled Depreciation	102.1K	229K	480K	704K	633.6K	406.8K

When determining whether Ocugen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ocugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ocugen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ocugen Inc Stock:

How To Invest In Ocugen

Details

Is Ocugen Stock a good investment?

Details

What is Ocugen's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ocugen. If investors know Ocugen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ocugen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.19)

Revenue Per Share

0.018

Quarterly Revenue Growth

1.353

Return On Assets

(0.48)

Return On Equity

(1.03)

The market value of Ocugen Inc is measured differently than its book value, which is the value of Ocugen that is recorded on the company's balance sheet. Investors also form their own opinion of Ocugen's value that differs from its market value or its book value, called intrinsic value, which is Ocugen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ocugen's market value can be influenced by many factors that don't directly affect Ocugen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ocugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ocugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ocugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ocugen Historical Income Statement

About Ocugen Income Statement Analysis

Ocugen Income Statement Chart

Other Operating Expenses

Total Operating Expenses

Ocugen income statement Correlations

Ocugen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ocugen income statement Accounts

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax
Other Operating Expenses	+ 0.98	Selling General Administrative
Total Operating Expenses	+ 0.98	Selling General Administrative
Ebit	+ 0.96	Operating Income

Income Tax Expense	- 0.96	Total Other Income Expense Net
Total Operating Expenses	- 0.95	Operating Income
Operating Income	- 0.95	Other Operating Expenses
Research Development	- 0.94	Operating Income
Operating Income	- 0.92	Selling General Administrative
Net Income	- 0.91	Total Operating Expenses